{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:06:08Z","timestamp":1760295968530},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2001,3,1]],"date-time":"2001-03-01T00:00:00Z","timestamp":983404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2001,3]]},"DOI":"10.1006\/gyno.2000.6090","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T22:50:18Z","timestamp":1032303018000},"page":"383-386","source":"Crossref","is-referenced-by-count":4,"title":["Serum Levels of Macrophage Colony-Stimulating Factor in Trophoblastic Disease"],"prefix":"10.1006","volume":"80","author":[{"given":"Ernest I.","family":"Kohorn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry M.","family":"Kacinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.Richard","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/gyno.2000.6090_RF1","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1182\/blood.V77.8.1796.1796","article-title":"Increased circulating colony-stimulating factor-1 in patients with preleukemia, leukemia, and lymphoid malignancies","volume":"77","author":"Janowska-Wieczorek","year":"1991","journal-title":"Blood"},{"key":"10.1006\/gyno.2000.6090_RF2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0360-3016(89)90383-0","article-title":"Circulating levels of CSF-1 (M-CSF) a lymphohematopoietic cytokine may be a useful marker of disease status in patients with malignant ovarian neoplasms","volume":"17","author":"Kacinski","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1006\/gyno.2000.6090_RF3","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0002-9378(12)90761-9","article-title":"Increased serum levels of macrophage colony-stimulating factor in ovarian cancer","volume":"165","author":"Xu","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1006\/gyno.2000.6090_RF4","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0360-3016(90)90488-6","article-title":"The cytokine CSF-1 (M-CSF) expressed by endometrial carcinomas in vivo and in vitro may also be a circulating tumor marker of neoplastic disease activity in endometrial carcinoma patients","volume":"19","author":"Kacinski","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1006\/gyno.2000.6090_RF5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0002-9378(95)90178-7","article-title":"Macrophage colony-stimulating factor 1, a clinically useful tumor marker in endometrial adenocarcinoma: comparison with CA-125 and the amino-terminal propeptide of type III procollagen","volume":"173","author":"Hakala","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1006\/gyno.2000.6090_RF6","series-title":"The physiological and pathological effects of cytokines","article-title":"The macrophage colony stimulating factor CSF-1, an auto- and paracrine tumor cytokine is also a circulating \u201ctumor marker\u201d in patients with ovarian, endometrial and pulmonary neoplasms","author":"Kacinski","year":"1990"},{"key":"10.1006\/gyno.2000.6090_RF7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1095\/biolreprod46.1.48","article-title":"Expression of the colony-stimulating factor-1 receptor (c-fms proto-oncogene product) in the human uterus and placenta","volume":"46","author":"Pampfer","year":"1992","journal-title":"Biol Reprod"},{"key":"10.1006\/gyno.2000.6090_RF8","doi-asserted-by":"crossref","unstructured":"Vaitukaitis, J, L, Braunstein, G, D, Ross, G, T. a radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone. Am J Obstet Gynecol113:751\u20131972.","DOI":"10.1016\/0002-9378(72)90553-4"},{"key":"10.1006\/gyno.2000.6090_RF9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/clinchem\/38.2.263","article-title":"Discordant results in human chorionic gonadotrophin assays","volume":"38","author":"Cole","year":"1992","journal-title":"Clin Chem"},{"key":"10.1006\/gyno.2000.6090_RF10","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1210\/jc.74.4.850","article-title":"Expression of colony-stimulating factor-1 in the human uterus and placenta","volume":"74","author":"Daiter","year":"1992","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825800960906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825800960906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T05:09:28Z","timestamp":1620018568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825800960906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,3]]}},"alternative-id":["S0090825800960906"],"URL":"https:\/\/doi.org\/10.1006\/gyno.2000.6090","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2001,3]]}}}